{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,4]],"date-time":"2026-08-04T11:46:55Z","timestamp":1785844015541,"version":"3.56.0"},"reference-count":27,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,5,27]],"date-time":"2026-05-27T00:00:00Z","timestamp":1779840000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["clinicalkey.fr","em-consulte.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Archives de P\u00e9diatrie"],"published-print":{"date-parts":[[2026,8]]},"DOI":"10.1016\/j.arcped.2026.105578","type":"journal-article","created":{"date-parts":[[2026,7,24]],"date-time":"2026-07-24T12:05:07Z","timestamp":1784894707000},"page":"105578","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Bronchodilator reversibility in children with cystic fibrosis: prevalence and associated factors"],"prefix":"10.1016","volume":"33","author":[{"given":"Astrid","family":"Harvey","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicole","family":"Beydon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0528-5458","authenticated-orcid":false,"given":"Guillaume","family":"Thouvenin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0002-9193-541X","authenticated-orcid":false,"given":"Elora","family":"Peulier-Maitre","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7552-3880","authenticated-orcid":false,"given":"Jessica","family":"Taytard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7026-7523","authenticated-orcid":false,"given":"Harriet","family":"Corvol","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.arcped.2026.105578_bib0001","doi-asserted-by":"crossref","first-page":"2519","DOI":"10.1016\/S0140-6736(16)00576-6","article-title":"Cystic fibrosis","volume":"388","author":"Elborn","year":"2016","journal-title":"Lancet"},{"key":"10.1016\/j.arcped.2026.105578_bib0002","unstructured":"Vaincre la mucoviscidose. [Internet] Registre fran\u00e7ais de la mucoviscidose: Bilan des donn\u00e9es 2024.https:\/\/www.vaincrelamuco.org\/sites\/default\/files\/bilan_annuel_ 2024_registre_francais_de_la_mucoviscidose.pdf; 2025 [accessed 13.04.2026]."},{"key":"10.1016\/j.arcped.2026.105578_bib0003","doi-asserted-by":"crossref","first-page":"eS13","DOI":"10.1016\/S0929-693X(20)30045-2","article-title":"Variant classifications, databases and genotype\u2013phenotype correlations","volume":"27","author":"Raynal","year":"2020","journal-title":"Arch Pediatr"},{"key":"10.1016\/j.arcped.2026.105578_bib0004","doi-asserted-by":"crossref","DOI":"10.3390\/ijms232214205","article-title":"Modifier factors of cystic fibrosis phenotypes: a focus on modifier genes","volume":"23","author":"M\u00e9sin\u00e8le","year":"2022","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.arcped.2026.105578_bib0005","doi-asserted-by":"crossref","first-page":"1859","DOI":"10.1001\/jama.2023.8120","article-title":"Cystic fibrosis: a review","volume":"329","author":"Ong","year":"2023","journal-title":"JAMA J Am Med Assoc"},{"key":"10.1016\/j.arcped.2026.105578_bib0006","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1016\/S1526-0550(02)00003-3","article-title":"Pseudomonas aeruginosa in cystic fibrosis: pathogenesis and persistence","volume":"3","author":"Davies","year":"2002","journal-title":"Paediatr Respir Rev"},{"key":"10.1016\/j.arcped.2026.105578_bib0007","doi-asserted-by":"crossref","first-page":"901","DOI":"10.1016\/j.jcf.2023.06.007","article-title":"Corvol H. Airway infections as a risk factor for Pseudomonas aeruginosa acquisition and chronic colonisation in children with cystic fibrosis","volume":"22","author":"M\u00e9sin\u00e8le","year":"2023","journal-title":"J Cyst Fibros"},{"key":"10.1016\/j.arcped.2026.105578_bib0008","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/j.jcf.2021.09.017","article-title":"Risk factors for Pseudomonas aeruginosa airway infection and lung function decline in children with cystic fibrosis","volume":"21","author":"M\u00e9sin\u00e8le","year":"2022","journal-title":"J Cyst Fibros"},{"key":"10.1016\/j.arcped.2026.105578_bib0009","article-title":"Long-acting inhaled bronchodilators for cystic fibrosis","volume":"2021","author":"Smith","year":"2017","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.arcped.2026.105578_bib0010","article-title":"Short-acting inhaled bronchodilators for cystic fibrosis","volume":"2022","author":"Smith","year":"2022","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.arcped.2026.105578_bib0011","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1016\/j.jcf.2023.02.004","article-title":"Elexacaftor\/tezacaftor\/ivacaftor projected survival and long-term health outcomes in people with cystic fibrosis homozygous for F508del","volume":"22","author":"Lopez","year":"2023","journal-title":"J Cyst Fibros"},{"key":"10.1016\/j.arcped.2026.105578_bib0012","doi-asserted-by":"crossref","first-page":"1769","DOI":"10.3390\/cells11111769","article-title":"CFTR modulators in people with cystic fibrosis: real-world evidence in France","volume":"11","author":"Regard","year":"2022","journal-title":"Cells"},{"key":"10.1016\/j.arcped.2026.105578_bib0013","doi-asserted-by":"crossref","first-page":"4778","DOI":"10.3390\/jcm14134778","article-title":"Assessment of bronchodilator response in patients with CF and non-CF bronchiectasis: a randomized controlled study","volume":"14","author":"Pollak","year":"2025","journal-title":"J Clin Med"},{"key":"10.1016\/j.arcped.2026.105578_bib0014","doi-asserted-by":"crossref","first-page":"957","DOI":"10.1164\/rccm.200705-664OC","article-title":"Cystic fibrosis pulmonary guidelines: chronic medications for maintenance of lung health","volume":"176","author":"Flume","year":"2007","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.arcped.2026.105578_bib0015","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1136\/thx.2004.028340","article-title":"Structural changes to airway smooth muscle in cystic fibrosis","volume":"60","author":"Hays","year":"2005","journal-title":"Thorax"},{"key":"10.1016\/j.arcped.2026.105578_bib0016","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/S2213-2600(12)70058-9","article-title":"How the airway smooth muscle in cystic fibrosis reacts in proinflammatory conditions","volume":"1","author":"McCuaig","year":"2013","journal-title":"Lancet Respir Med"},{"key":"10.1016\/j.arcped.2026.105578_bib0017","doi-asserted-by":"crossref","first-page":"488","DOI":"10.1016\/j.rmr.2024.06.005","article-title":"Pulmonary function test: testing of children","volume":"41","author":"Beydon","year":"2024","journal-title":"Rev Mal Respir"},{"key":"10.1016\/j.arcped.2026.105578_bib0018","doi-asserted-by":"crossref","first-page":"1099","DOI":"10.1164\/rccm.200205-421OC","article-title":"Pulmonary function tests in preschool children with cystic fibrosis","volume":"166","author":"Beydon","year":"2002","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.arcped.2026.105578_bib0019","article-title":"ERS\/ATS technical standard on interpretive strategies for routine lung function tests","volume":"60","author":"Stanojevic","year":"2022","journal-title":"Eur Respir J"},{"key":"10.1016\/j.arcped.2026.105578_bib0020","doi-asserted-by":"crossref","DOI":"10.1590\/1984-0462\/2024\/42\/2023162","article-title":"Bronchodilator response assessment through impulse oscillometry system and spirometry in children and adolescents with cystic fibrosis","volume":"42","author":"Castilho","year":"2024","journal-title":"Rev Paul Pediatr"},{"key":"10.1016\/j.arcped.2026.105578_bib0021","doi-asserted-by":"crossref","first-page":"652","DOI":"10.1016\/j.jcf.2016.01.003","article-title":"Reversible airway obstruction in cystic fibrosis","volume":"15","author":"Levine","year":"2016","journal-title":"J Cyst Fibros"},{"key":"10.1016\/j.arcped.2026.105578_bib0022","doi-asserted-by":"crossref","DOI":"10.3389\/fped.2022.856840","article-title":"Prevalence and determinants of wheezing and bronchodilatation in children with cystic fibrosis","volume":"10","author":"Galod\u00e9","year":"2022","journal-title":"Front Pediatr"},{"key":"10.1016\/j.arcped.2026.105578_bib0023","doi-asserted-by":"crossref","first-page":"4735","DOI":"10.3390\/jcm12144735","article-title":"Pulmonary function tests in early lung disease in cystic fibrosis","volume":"12","author":"Walicka-Serzysko","year":"2023","journal-title":"J Clin Med"},{"key":"10.1016\/j.arcped.2026.105578_bib0024","doi-asserted-by":"crossref","DOI":"10.3389\/fped.2025.1564156","article-title":"Beyond the present: current and future perspectives on infections in pediatric PCD","volume":"13","author":"Frohlich","year":"2025","journal-title":"Front Pediatr"},{"key":"10.1016\/j.arcped.2026.105578_bib0025","article-title":"Inhaled corticosteroids for cystic fibrosis","volume":"2021","author":"Balfour-Lynn","year":"2019","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.arcped.2026.105578_bib0026","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1016\/S2213-2600(25)00248-6","article-title":"Effect of elexacaftor-tezacaftor-ivacaftor on bronchial dilatations in adolescents with cystic fibrosis","volume":"14","author":"Sermet-Gaudelus","year":"2026","journal-title":"Lancet Respir Med"},{"key":"10.1016\/j.arcped.2026.105578_bib0027","doi-asserted-by":"crossref","first-page":"835","DOI":"10.1136\/thorax-2022-219943","article-title":"Effect of elexacaftor\/tezacaftor\/ivacaftor on airway and systemic inflammation in cystic fibrosis","volume":"78","author":"Casey","year":"2023","journal-title":"Thorax"}],"container-title":["Archives de P\u00e9diatrie"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0929693X26001247?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0929693X26001247?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,8,4]],"date-time":"2026-08-04T11:28:15Z","timestamp":1785842895000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0929693X26001247"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8]]},"references-count":27,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2026,8]]}},"alternative-id":["S0929693X26001247"],"URL":"https:\/\/doi.org\/10.1016\/j.arcped.2026.105578","relation":{},"ISSN":["0929-693X"],"issn-type":[{"value":"0929-693X","type":"print"}],"subject":[],"published":{"date-parts":[[2026,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Bronchodilator reversibility in children with cystic fibrosis: prevalence and associated factors","name":"articletitle","label":"Article Title"},{"value":"Archives de P\u00e9diatrie","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.arcped.2026.105578","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Author(s). Published by Elsevier Masson SAS on behalf of Soci\u00e9t\u00e9 fran\u00e7aise de p\u00e9diatrie.","name":"copyright","label":"Copyright"}],"article-number":"105578"}}